Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Wong

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Nature Immunology|April 18, 2024
Fat matters for natural killer cell activityPamela Wong, Todd A Fehniger
Australian Orthodontic Journal|January 26, 2006
Patients' attitudes towards compliance with retainer wearPamela Wong, Terry J Freer
American Journal of Ophthalmology|July 29, 2011
Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trialsPhilip J Rosenfeld, Howard Shapiro, Jason S Ehrlich, et al.
Magnetic Resonance Imaging|November 1, 2015
Hemodynamic safety and efficacy of ferumoxytol as an intravenous contrast agents in pediatric patients and young adultsPeigang Ning, Evan J Zucker, Pamela Wong, et al.
Seminars in Hematology|December 1, 2020
Memory-like natural killer cells for cancer immunotherapyMargery Gang, Pamela Wong, Melissa M Berrien-Elliott, et al.
Retina (Philadelphia, Pa.)|August 5, 2010
Dosing regimen and the frequency of macular hemorrhages in neovascular age-related macular degeneration treated with ranibizumabIrene Barbazetto, Namrata Saroj, Howard Shapiro, et al.
Autoimmune Diseases|December 26, 2013
Composite Indices Using 3 or 4 Components of the Core Data Set Have Similar Predictive Ability to Measure Disease Activity in RA: Evidence from the DANCER and REFLEX StudiesMartin J Bergman, William Reiss, Carol Chung, et al.
Journal of Ophthalmology|December 20, 2012
Fixed Monthly versus Less Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-Related Macular DegenerationSeenu M Hariprasad, Lawrence S Morse, Howard Shapiro, et al.
Retina (Philadelphia, Pa.)|October 5, 2010
An observational retrospective subgroup analysis of verteporfin photodynamic therapy-naive and previously treated patients in the focus trialRajendra S Apte, Sherri L Alexander, Erin C Henry, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 12, 2012
Long-term effects of ranibizumab on diabetic retinopathy severity and progressionMichael S Ip, Amitha Domalpally, J Jill Hopkins, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Nature Immunology|April 18, 2024
Fat matters for natural killer cell activityPamela Wong, Todd A Fehniger
Australian Orthodontic Journal|January 26, 2006
Patients' attitudes towards compliance with retainer wearPamela Wong, Terry J Freer
American Journal of Ophthalmology|July 29, 2011
Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trialsPhilip J Rosenfeld, Howard Shapiro, Jason S Ehrlich, et al.
Magnetic Resonance Imaging|November 1, 2015
Hemodynamic safety and efficacy of ferumoxytol as an intravenous contrast agents in pediatric patients and young adultsPeigang Ning, Evan J Zucker, Pamela Wong, et al.
Seminars in Hematology|December 1, 2020
Memory-like natural killer cells for cancer immunotherapyMargery Gang, Pamela Wong, Melissa M Berrien-Elliott, et al.
Retina (Philadelphia, Pa.)|August 5, 2010
Dosing regimen and the frequency of macular hemorrhages in neovascular age-related macular degeneration treated with ranibizumabIrene Barbazetto, Namrata Saroj, Howard Shapiro, et al.
Autoimmune Diseases|December 26, 2013
Composite Indices Using 3 or 4 Components of the Core Data Set Have Similar Predictive Ability to Measure Disease Activity in RA: Evidence from the DANCER and REFLEX StudiesMartin J Bergman, William Reiss, Carol Chung, et al.
Journal of Ophthalmology|December 20, 2012
Fixed Monthly versus Less Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-Related Macular DegenerationSeenu M Hariprasad, Lawrence S Morse, Howard Shapiro, et al.
Retina (Philadelphia, Pa.)|October 5, 2010
An observational retrospective subgroup analysis of verteporfin photodynamic therapy-naive and previously treated patients in the focus trialRajendra S Apte, Sherri L Alexander, Erin C Henry, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 12, 2012
Long-term effects of ranibizumab on diabetic retinopathy severity and progressionMichael S Ip, Amitha Domalpally, J Jill Hopkins, et al.
Pageof 6